Baker Brothers Advisors - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$10,049,000
+0.6%
73,3860.0%0.09%
+7.4%
Q3 2017$9,992,000
+12.2%
73,3860.0%0.08%
+3.8%
Q2 2017$8,909,000
+14.7%
73,3860.0%0.08%
+21.9%
Q1 2017$7,767,000
+4.2%
73,3860.0%0.06%
-12.3%
Q4 2016$7,457,000
-0.4%
73,3860.0%0.07%
+7.4%
Q3 2016$7,490,000
-14.4%
73,3860.0%0.07%
-26.1%
Q2 2016$8,753,000
+11.4%
73,3860.0%0.09%
+10.8%
Q1 2016$7,859,000
-1.2%
73,3860.0%0.08%
+25.8%
Q4 2015$7,957,000
+26.6%
73,3860.0%0.07%
+13.8%
Q3 2015$6,286,000
-15.1%
73,3860.0%0.06%
-10.8%
Q2 2015$7,405,000
+30.9%
73,3860.0%0.06%
+38.3%
Q1 2015$5,659,000
+44.9%
73,386
-0.0%
0.05%
+17.5%
Q4 2014$3,906,000
+13.3%
73,4000.0%0.04%
-7.0%
Q3 2014$3,449,000
-24.6%
73,4000.0%0.04%
-23.2%
Q2 2014$4,572,000
-7.4%
73,4000.0%0.06%
-11.1%
Q1 2014$4,937,00073,4000.06%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders